Relationship between T-cells subsets and prognostic markers in HIV-1-infected children;Relación de las subpoblaciones de linfocitos T con los marcadores pronósticos de la infección pediátrica por el virus de la inmunodeficiencia humana

Medicina Clinica

Volumn 117, Issue 6, 2001, Pages 201-206

  Resino, Salvador ^a   Navarro, Joaquín ^a   Bellón, José Ma ^a   Gurbindo, Dolores ^a   León, Juan Antonio ^b   Muñoz Fernández, Ma Ángeles ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

CD4+ T cells; Children; HIV 1; T cell subsets; Viral load

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; CHILD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IMMUNOPHENOTYPING; PROGNOSIS; T LYMPHOCYTE SUBPOPULATION; VIROLOGY; VIRUS LOAD;

BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CHILD; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; PROGNOSIS; T-LYMPHOCYTE SUBSETS; VIRAL LOAD;

EID: 0035859683     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(01)72063-5     Document Type: Article

References (52)

1. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993; 262: 1011-1018.
2. Giorgi JV, Liu Z, Hultin LE, Cumber and WG, Hennessey K, Detels R. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. Cell Immunol 1993; 150: 72-80.
3. Phillips AN, Sabin CA, Elfod J, Bofill M, Lee CA, Janossy G. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up. AIDS 1993; 7: 975-980.
4. Jackson DG, Bell JI. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinous pattern of expression during lymphocyte differentiation. J Immunol 1990; 144: 2811-2815.
5. Plaeger-Marshall S, Isacescu V, O'Rourke S, Bertolli J, Bryson YJ, Stiehm ER. T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping. Clin Immunol Immunopathol 1994; 71: 27-32.
6. Mocroft A, Bofill M, Lipman M, Medina E, Borthwick N, Timms A et al. CD8+, CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 158-162.
7. Bass HZ, Nishanian P, Hardy WD, Mitsuyasu RT Esmail E, Cumberland W et al. Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin Immunol Immunopathol 1992; 64: 63-70.
8. De Martino M, Rossi ME, Azzari C, Gelli MG, Galli L, Vierucci A. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years. Pediatr Res 1998; 43: 752-758.
9. Clement LT, Yamashita N, Martin AM. The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation. J Immunol 1988; 141: 1464-1470.
10. Akbar AN, Terry L, Timms A, Beverley PC, Janossy G. Loss of CD45R and gain of UCHL 1 reactivity is a feature of primed T cells. J Immunol 1988; 140: 2171-2178.
11. Bradley LM, Bradley JS, Ching DL, Shiigi SM. Predominance of T cells that express CD45R in he CD4+ helper/inducer lymphocyte subset of neonates. Clin Immunol Immunopathol 1989; 51: 426-435.
12. De Paoli P, Battistin S, Santini GF. Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population. Clin Immuno Immunopathol 1988; 48. 290-296.
13. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, Terstappen LW. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition. J Immunol 1993; 150: 1105-1121.
14. Sleasman JW, Aleixo LF, Morton A, Skoda-Smith S, Goodenow MM. CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children. AIDS 1996; 10: 1477-1484.
15. Rabin RL, Roederer M, Maldonado Y, Petry A, Herzenberg LA. Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. J Clin Invest 1995; 95: 2054-2060.
16. Brinchmann JE, Dobloug JH, Hegger BH, Haaheim LL, Sannes M, Egeland T. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations J Infect Dis 1994; 169: 730-738.
17. Hengel RL, Jones BM, Kennedy MS, Hubbard MW, McDougal JS. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans. J Immunol 1999; 163: 3539-3548.
18. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA 1997; 277: 1962-1969.
19. Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA 1998; 280: 72-77.
20. Franco JM, León-Leal JA, Leal M, Cano-Rodríguez A, Pineda JA, Macias J et al. CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1 infected children and adult patients. Clin Exp Immunol 2000, 119: 493-498.
21. Gibb DM, Newberry A, Klein N, De Rossi A, Grosch-Woerner I, Babiker A. Immune repopulation after HAART in previously untreated HIV-1 infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee. Lancet 2000; 355: 1331-1332.
22. Muñoz-Fernández MA, Obregón E, Navarro J, Borner C, Gurbindo MD, Sampelayo TH et al. Relationship of virologic, immunologic, and clinical paramters in infants with vertically acquired human immunodeficiency virus type 1 infection. Pediatr Res 1996; 40: 597-602.
23. CDCP. Center for Diseases Control and Prevention. Revised classification system for HIV-1 infection in children less than 13 years of age. MMWR 1994; 43: 1-13.
24. CDCP. Guidelines for use antiretroviral agents in pediatric HIV infection. MMWR 1998; 47: RR-4.
25. Pediatric European Network for treatment of AIDS (PENTA). HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. AIDS 1998; 12: F1-F8.
26. CDCP. Center for Diseases Control and Prevention. Revised for guidelines for performing CD4+ T-cell determiations in persons with human immunodeficiency virus (HIV). MMWR 1997; 46: 1-29.
27. Nicholson J, Kidd P, Mandy F, Livnat D, Kagan J. Three-color supplement to the NIAID DAIDS guideline for flow cytometric immunophenotyping. Cytometry 1996, 26: 227-230.
28. Nicholson JK, Hubbard M, Jones BM. Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. Cytometry 1996; 26: 16-21.
29. Resino S, Bellón JM, Gurbindo D, Ramos JT, Ruiz-Contreras J, Muñoz-Fernández MA. Marcadores predictives de progresión a sida en niños infectados por transmisión vertical por el virus de la inmunodeficiencia humana tipo 1. Med Clin (Barc) 2000; 115: 564-567.
30. Resino S, Gurbindo MD, Bellón JM, Sánchez-Ramón S, Muñoz-Fernández MA. Predictive markers of clinical outcome in vertically HIV-1 infected infants. A prospective longitudinal study. Pediatr Res 2000; 47: 509-515.
31. Pizzo PA, Wilfert CM. Markers and determinants of disease progression in children with HIV infection. The Pediatric AIDS Siena Workshop II. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 30-44.
32. Bouscarat F, Levacher-Clergeor M, Dazza MC, Strauss KW, Girar PM, Ruggery C et al. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res Human Retroviruses 1996, 12: 17-24.
33. Bouscarat F, Levacher M, Dazza MC, Chau F, Desforges B, Muffat-Joly M et al. Prospective study of CD8+ lymphocyte activation in relation to viral load in HIV-infected patients with > or = 400 CD4+ lymphocytes per microliter. AIDS Res Hum Retroviruses 1999; 15: 1419-1425.
34. Landay AL, Mackewicz CE, Levy JA. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Proc Natl Acad Sci USA 1993; 90: 9427-9430.
35. Yu DT, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Hunkel HG. Peripheral blood Ia-positive T cells. Increases in certain diseass and after immunization. J Exp Med 1980; 151: 91-100.
36. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179: 859-870.
37. Burgisser P, Hammann C, Kaufmann D, Battegay M, Rutschmann OT. Expression of CD28 and CD38 by CD8+ lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study. Clin Exp Immunol 1999; 115: 458-463.
38. Bofill M, Mocroft A, Lipman M, Medina E, Borthwick NJ, Sabin CA et al. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS 1996; 10: 827-834.
39. Borkowsky W, Moore T, Krasinski K, Ajuang-Simbiri KO, Holzman R. Evolution of phenotypic memory T cells in HIV-1 infected infants and children. Clin Immunol Immunopathol 1992; 63: 280-284.
40. Kestens L, Vanham G, Vereecken C, Vandenoruaene M, Vercauteren G, Colebunders RL et al. Selective increase of activation antigens HLA-DR and CD38 on CD4+CD45RO+ T lymphocytes during HIV-1 infection. Clin Exp Immunol 1994; 95: 436-441.
41. Pantaleo G, Demarest JF, Soudenys H, Graziosi C, Denis F, Adelsberger JW et al. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Cell 1994, 78: 373-387.
42. Maini MK, Casorati G, Dellabona P, Wack A, Beverley PC. T-cell clonality in immune responses. Immunol Today 1999; 20: 262-266.
43. Caruso A, Licenziati S, Canaris AD, Cantalamessa A, Fiorentini S, Ausenda S et al. Contribution of CD4+, CD8+CD28+, and CD8+CD28 - T cells to CD3+ lymphocyte homeostasis during the natural course of HIV-1 infection. J Clin Invest 1998, 101: 137-144.
44. Fiorentino S, Dalod M, Olive D, Guillet JG, Gomard E. Predominant involvement of CD8+CD28- lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J Virol 1996; 70: 2022-2026.
45. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998; 279: 2103-2106.
46. Dalod M, Harzic M, Peregrin I, Dumon B, Hoen B, Sereni D et al. Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy. J Infect Dis 1998, 178: 61-69.
47. Ogg GS, Jin X, Bonhoeffer S, Moss P, Nowak MA, Monard S et al. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol 1999; 73: 797-800.
48. Spiegel HM, DeFalcon E, Ogg GS, Larsson M, Beadle TJ, Tao P et al. Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children. J Infec Dis 1999; 180: 359-368.
49. Connors M, Kovacs JA, Krevat S, Gea-Banacloche JC, Sneller MC, Flanigan M et al. HIV infection induces changes in CD4+ T-cell ptienotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997; 3: 533-540.
50. Stanley SK, McCune JM, Kaneshima M, Justemnt JS, Sullivan M, Boone E et al. Human immunodeficincy virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Infect Dis 1993; 168: 810-817.
51. Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM et al. HIV induces thymus depletion in vivo. Nature 1993; 363: 728-732.
52. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117-122.